Astrana Health Reports Q3 Non-GAAP EPS Miss Amid In-Line Revenue Growth
Astrana Health (ASTH) reported third-quarter financial results that featured a significant miss on earnings per share. The company's Non-GAAP EPS came in at $0.71, falling $0.17 short of expectations. However, revenue met market expectations, totaling $1.02 billion, which represents a 6.7% increase year-over-year. The company's Care Partners segment drove much of the activity, generating $968.8 million in revenue, an 8% increase compared to the previous year. Despite the earnings miss, Astrana provided full-year guidance for total revenue between $3.9 billion and $4.0 billion, alongside adjusted EBITDA projections ranging from $261 million to $274 million.
Tickers: $ASTH
Topics: earnings miss financial guidance non-GAAP EPS revenue growth